Sodium-potassium ATPase emerges as a player in hippocampal phenotypes of Angelman syndrome mice.
Open Access
- 1 July 2014
- journal article
- editorial
- Published by American Physiological Society in Journal of Neurophysiology
- Vol. 112 (1) , 5-8
Abstract
Angelman syndrome is a neurodevelopmental disorder characterized by intellectual disabilities, ataxia, and unusually happy affect. The hippocampal pyramidal cells of Angelman syndrome model mice have altered intrinsic membrane properties, which Kaphzan et al. ( Cell Rep 4: 405–412, 2013) demonstrate can be corrected by genetic reduction of the α1-subunit of the sodium-potassium ATPase. Intriguingly, this manipulation also restores hippocampal long-term potentiation and learning. In this Neuro Forum, we discuss translational implications of this work and remaining questions left in its wake.Keywords
This publication has 32 references indexed in Scilit:
- The Angelman Syndrome Protein Ube3a/E6AP Is Required for Golgi Acidification and Surface Protein SialylationJournal of Neuroscience, 2013
- Impairment of TrkB-PSD-95 Signaling in Angelman SyndromePLOS Biology, 2013
- Metabolic biomarkers related to energy metabolism in Saudi autistic childrenClinical Biochemistry, 2009
- Role of hippocampal sodium channel Nav1.6 in kindling epileptogenesisEpilepsia, 2009
- Introduction. The blurred boundary between channels and transportersPhilosophical Transactions of the Royal Society B: Biological Sciences, 2008
- New roles for an old enzyme: Na,K‐ATPase emerges as an interesting drug targetJournal of Internal Medicine, 2007
- Angelman Syndrome Reviewed from a Neurophysiological Perspective. TheUBE3A-GABRB3HypothesisNeuropediatrics, 2003
- Mice Lacking the β3Subunit of the GABAAReceptor Have the Epilepsy Phenotype and Many of the Behavioral Characteristics of Angelman SyndromeThe Journal of Neuroscience, 1998
- Ubiquitination of Na,K‐ATPase α1 and α2 subunitsFEBS Letters, 1997
- ‘Puppet’ Children A Report on Three CasesDevelopmental Medicine & Child Neurology, 1965